project id: TCGA-BRCA; case submitter id: TCGA-GM-A5PX; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.63; rna integrity number: 8.3; age at index: 65; days to birth: -23753; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1946; age at diagnosis: 23753; ajcc pathologic m: M0; ajcc pathologic n: N1mi; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 551.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8520/3; primary diagnosis: Lobular carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 616; initial weight: 110.0; oct embedded: false; preservation method: Unknown; sample id: 2678d877-e48e-48e3-95c1-65ecce46308e; sample submitter id: TCGA-GM-A5PX-01A; portion id: 4bb12bd8-80c8-437a-b30a-54aabef40018; portion submitter id: TCGA-GM-A5PX-01A-12; slide id: b6353d86-b0cd-464c-b976-752100d5cae8; slide submitter id: TCGA-GM-A5PX-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 70.0; section location: TOP;